glp-1 shortage update Deepens in Two States as Demand Remains High GLP-1 Drug Shortage 2024: What
Description
While some patients report increased skin dryness or sensitivity to touch, temperature, or topical products during treatment, these symptoms are not definitively linked to semaglutide and may have other causes that should be evaluated by a healthcare provider
Ther Adv Endocrinol Metab
The drug, called Livdelzi, will be sold by Gilead Sciences, following the $4.3 billion acquisition of CymaBay Therapeutics, its developer, earlier this year
Others may find that the allodynia returns at the same dose threshold
